New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety
PHILADELPHIA, PA – (BUSINESS WIRE) – November 2, 2022 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that the latest edition of its powerful Leadscope Model Applier Computational Toxicology software solution has been released.
May 10, 2022 - Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines
November 22, 2021 - Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods
Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently
September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support
July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance
2nd Annual Genotoxic Impurities Summit: Nitrosamines & Beyond 2022
December 1 - 2, 2022
'The use of Structure-Activity Relationships in the Risk Assessment of Nitrosamines'
Dr. Kevin Cross
Computational Toxicology Release Webcast 2022
December 7, 2022
Dr. Glenn Myatt, VP of Informatics, will reveal the latest edition of our Computational Toxicology software suite which supports detailed predictions of chemical safety.
PHUSE Winter Data Transparency Event
February 7 - 9, 2023